Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 2
1983 2
1995 1
1996 1
1997 2
1998 3
1999 1
2000 1
2001 1
2002 2
2003 1
2004 3
2006 3
2007 1
2008 4
2009 1
2011 1
2012 1
2014 1
2015 1
2017 1
2018 2
2019 2
2020 4
2021 1
2022 6
2023 5
2024 3
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus.
Werth VP, Furie RA, Romero-Diaz J, Navarra S, Kalunian K, van Vollenhoven RF, Nyberg F, Kaffenberger BH, Sheikh SZ, Radunovic G, Huang X, Clark G, Carroll H, Naik H, Gaudreault F, Meyers A, Barbey C, Musselli C, Franchimont N; LILAC Trial Investigators. Werth VP, et al. N Engl J Med. 2022 Jul 28;387(4):321-331. doi: 10.1056/NEJMoa2118024. N Engl J Med. 2022. PMID: 35939578 Clinical Trial.
Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus.
Furie RA, van Vollenhoven RF, Kalunian K, Navarra S, Romero-Diaz J, Werth VP, Huang X, Clark G, Carroll H, Meyers A, Musselli C, Barbey C, Franchimont N; LILAC Trial Investigators. Furie RA, et al. N Engl J Med. 2022 Sep 8;387(10):894-904. doi: 10.1056/NEJMoa2118025. N Engl J Med. 2022. PMID: 36069871 Clinical Trial.
A Randomized, Placebo-Controlled Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled Gout Receiving Pegloticase: Primary Efficacy and Safety Findings.
Botson JK, Saag K, Peterson J, Parikh N, Ong S, La D, LoCicero K, Obermeyer K, Xin Y, Chamberlain J, LaMoreaux B, Verma S, Sainati S, Grewal S, Majjhoo A, Tesser JRP, Weinblatt ME. Botson JK, et al. Among authors: tesser jrp. Arthritis Rheumatol. 2023 Feb;75(2):293-304. doi: 10.1002/art.42335. Epub 2022 Dec 16. Arthritis Rheumatol. 2023. PMID: 36099211 Free PMC article. Clinical Trial.
A Randomized, Double-Blind, Placebo-Controlled Multicenter Efficacy and Safety Study of Methotrexate to Increase Response Rates in Patients With Uncontrolled Gout Receiving Pegloticase: 12-Month Findings.
Botson JK, Saag K, Peterson J, Obermeyer K, Xin Y, LaMoreaux B, Padnick-Silver L, Verma S, Grewal S, Majjhoo A, Tesser JRP, Weinblatt ME. Botson JK, et al. Among authors: tesser jrp. ACR Open Rheumatol. 2023 Aug;5(8):407-418. doi: 10.1002/acr2.11578. Epub 2023 Jun 29. ACR Open Rheumatol. 2023. PMID: 37385296 Free PMC article.
Biosimilars Have Arrived: Rituximab.
Greenwald M, Tesser J, Sewell KL. Greenwald M, et al. Among authors: tesser j. Arthritis. 2018 Mar 22;2018:3762864. doi: 10.1155/2018/3762864. eCollection 2018. Arthritis. 2018. PMID: 29765782 Free PMC article. Review.
The liver in rheumatic diseases.
Weinblatt ME, Tesser JR, Gilliam JH 3rd. Weinblatt ME, et al. Among authors: tesser jr. Semin Arthritis Rheum. 1982 May;11(4):399-405. doi: 10.1016/0049-0172(82)90027-0. Semin Arthritis Rheum. 1982. PMID: 7048531 Review. No abstract available.
Durable control of psoriatic arthritis with guselkumab across domains and patient characteristics: post hoc analysis of a phase 3 study.
Ritchlin CT, Mease PJ, Boehncke WH, Tesser J, Chakravarty SD, Rampakakis E, Shawi M, Schiopu E, Merola JF, McInnes IB, Deodhar A. Ritchlin CT, et al. Among authors: tesser j. Clin Rheumatol. 2024 Aug;43(8):2551-2563. doi: 10.1007/s10067-024-06991-8. Epub 2024 Jun 7. Clin Rheumatol. 2024. PMID: 38844682 Free PMC article. Clinical Trial.
52 results